MANILA, Philippines — The Department of Health (DOH) said Thursday that current stocks of COVID-19 investigational drugs remdesivir and tocilizumab are diminishing amid the fresh surge of cases.
For this, the health agency vowed to provide P5 million funding to each DOH hospital in Metro Manila, Central Luzon, and Calabarzon “to ensure unhampered supply of COVID-19 therapeutics.”
“The current stocks of remdesivir and tocilizumab are running low. The remaining supplies being used by select hospitals are donations from the WHO (World Health Organization),” DOH said.
Use of these investigational drugs was allowed under the compassionate use permit of the Food and Drug Adminis…
Keep on reading: Stocks of remdesivir, tocilizumab in PH running low – DOH